RxDoctor Payments Data

Kalpana Hari Hall, MD

Sleep Medicine · Washington, DCNPI 1366414609

Payments from drug & device makers

$3,760in general payments, 2019–2025

Across 76 payments — averaging $49.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • AbbVie$778
  • Novartis$132
  • MDD US Operations, LLC$117
  • Pfizer$85
  • Sunovion Pharmaceuticals Inc.$65
  • plus $189 from 6 others

What the payments were for

  • Travel & lodging$1,96252%
  • Food & beverage$1,79848%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few sleep medicine providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$477,729
Medicare patients
927
Services billed
4,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate12$58,797
Aimovig AutoinjectorErenumab-Aooe29$27,878
AptiomEslicarbazepine Acetate11$24,365
RytaryCarbidopa/Levodopa14$23,610
Nurtec OdtRimegepant Sulfate17$22,088
UbrelvyUbrogepant11$12,970
Memantine Hcl ErMemantine Hcl46$9,975
Emgality PenGalcanezumab-Gnlm11$8,762
Memantine Hcl177$7,828
Ajovy SyringeFremanezumab-Vfrm11$7,782
BelsomraSuvorexant17$7,267
Rivastigmine20$6,952
Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone18$6,444
Modafinil45$5,851
Levetiracetam48$4,378

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sunovion Pharmaceuticals Inc.Aptiom$65$24,36511 claims
PfizerNurtec Odt$85$22,08817 claims
AbbVieUbrelvy$778$12,97011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few sleep medicine providers in District of Columbiaon file to place this against a meaningful peer group, so we don't.

Other sleep medicine in Washington

Where these figures come from

Is this you, or does something look wrong? →